J Dig Cancer Res.
2023 Aug;11(2):93-98. 10.52927/jdcr.2023.11.2.93.
Endoscopic Management of Ampullary Tumors
- Affiliations
-
- 1Department of Gastroenterology, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
- KMID: 2545357
- DOI: http://doi.org/10.52927/jdcr.2023.11.2.93
Abstract
- Ampullary tumor is a rare disease whose prevalence rate has increased gradually in recent years with the increase in endoscopic examinations. Ampullary lesions are observed via endoscopy, and biopsy is done to determine whether such lesions are adenomas or carcinomas. Endoscopic papillectomy is performed on ampullary adenomas without intraductal lesions. Before the procedure, bleeding tendencies and pancreatitis are assessed, and the lesion is resected using a high-frequency wave and a thin wire snare. Thereafter, pancreatic duct stent insertion or clipping of the resection site is performed to prevent postprocedural pancreatitis. Although 47–93% of the patients achieve complete endoscopic papillary resection, the recurrence rate is 5–31%. Hence, regular follow-up via endoscopy is required.
